Literature DB >> 17945184

NMR structural studies of the antibiotic lipopeptide daptomycin in DHPC micelles.

Walter R P Scott1, Seung-Bin Baek, David Jung, Robert E W Hancock, Suzana K Straus.   

Abstract

Daptomycin is a cyclic anionic lipopeptide that exerts its rapid bactericidal effect by perturbing the bacterial cell membrane, a mode of action different from most other currently commercially available antibiotics (except e.g. polymyxin and gramicidin). Recent work has shown that daptomycin requires calcium in the form of Ca2+ to form a micellar structure in solution and to bind to bacterial model membranes. This evidence sheds light on the initial steps in the mechanism of action of this novel antibiotic. To understand how daptomycin goes on to perturb bacterial membranes, its three-dimensional structure has been determined in the presence of 1,2-dihexanoyl-sn-glycero-3-phosphocholine (DHPC) micelles. NMR spectra of daptomycin in DHPC were obtained under two conditions, namely in the presence of Ca2+ as used by Jung et al. [D. Jung, A. Rozek, M. Okon, R.E.W. Hancock, Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin, Chem. Biol. 11 (2004) 949-57] to solve the calcium-conjugated structure of daptomycin in solution and in a phosphate buffer as used by Rotondi and Gierasch [K.S. Rotondi, L.M. Gierasch, A well-defined amphipathic conformation for the calcium-free cyclic lipopeptide antibiotic, daptomycin, in aqueous solution, Biopolymers 80 (2005) 374-85] to solve the structure of apo-daptomycin. The structures were calculated using molecular dynamics time-averaged refinement. The different sample conditions used to obtain the NMR spectra are discussed in light of fluorescence data, lipid flip-flop and calcein release assays in PC liposomes, in the presence and absence of Ca2+ [D. Jung, A. Rozek, M. Okon, R.E.W. Hancock, Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin, Chem. Biol. 11 (2004) 949-57]. The implications of these results for the membrane perturbation mechanism of daptomycin are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17945184     DOI: 10.1016/j.bbamem.2007.08.034

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  23 in total

1.  Ubiquitous detection of gram-positive bacteria with bioorthogonal magnetofluorescent nanoparticles.

Authors:  Hyun Jung Chung; Thomas Reiner; Ghyslain Budin; Changwook Min; Monty Liong; David Issadore; Hakho Lee; Ralph Weissleder
Journal:  ACS Nano       Date:  2011-10-10       Impact factor: 15.881

Review 2.  Mechanisms of drug resistance: daptomycin resistance.

Authors:  Truc T Tran; Jose M Munita; Cesar A Arias
Journal:  Ann N Y Acad Sci       Date:  2015-10-23       Impact factor: 5.691

Review 3.  How nature morphs peptide scaffolds into antibiotics.

Authors:  Elizabeth M Nolan; Christopher T Walsh
Journal:  Chembiochem       Date:  2009-01-05       Impact factor: 3.164

4.  Molecular State of the Membrane-Active Antibiotic Daptomycin.

Authors:  Ming-Tao Lee; Wei-Chin Hung; Meng-Hsuan Hsieh; Hsiung Chen; Yu-Yung Chang; Huey W Huang
Journal:  Biophys J       Date:  2017-07-11       Impact factor: 4.033

Review 5.  Daptomycin, a bacterial lipopeptide synthesized by a nonribosomal machinery.

Authors:  Lars Robbel; Mohamed A Marahiel
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

Review 6.  Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci.

Authors:  William R Miller; Arnold S Bayer; Cesar A Arias
Journal:  Cold Spring Harb Perspect Med       Date:  2016-11-01       Impact factor: 6.915

7.  Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains.

Authors:  Anna Müller; Michaela Wenzel; Henrik Strahl; Fabian Grein; Terrens N V Saaki; Bastian Kohl; Tjalling Siersma; Julia E Bandow; Hans-Georg Sahl; Tanja Schneider; Leendert W Hamoen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-24       Impact factor: 11.205

8.  An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus.

Authors:  Longzhu Cui; Taisuke Isii; Minoru Fukuda; Tomonori Ochiai; Hui-Min Neoh; Ilana Lopes Baratella da Cunha Camargo; Yukiko Watanabe; Mitsutaka Shoji; Tomomi Hishinuma; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2010-09-13       Impact factor: 5.191

9.  Mechanism of action and limited cross-resistance of new lipopeptide MX-2401.

Authors:  E Rubinchik; T Schneider; M Elliott; W R P Scott; J Pan; C Anklin; H Yang; D Dugourd; A Müller; K Gries; S K Straus; H G Sahl; R E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2011-04-04       Impact factor: 5.191

Review 10.  Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall.

Authors:  Arnold S Bayer; Tanja Schneider; Hans-Georg Sahl
Journal:  Ann N Y Acad Sci       Date:  2012-12-05       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.